Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP323228.RAcZsLzNqt4HP_EJJvNPUqe9ucEXTTsJMY1CoT6pM8UOY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP323228.RAcZsLzNqt4HP_EJJvNPUqe9ucEXTTsJMY1CoT6pM8UOY130_assertion type Assertion NP323228.RAcZsLzNqt4HP_EJJvNPUqe9ucEXTTsJMY1CoT6pM8UOY130_head.
- NP323228.RAcZsLzNqt4HP_EJJvNPUqe9ucEXTTsJMY1CoT6pM8UOY130_assertion description "[In 18 patients with chronic active hepatitis C, we determined the Montgomery and Asberg Rating Scale (MADRS), the Hamilton Anxiety Rating Scale (HAM-A), serum DPP IV activity, the kynurenine/tryptophan (K/T) quotient, which is an indicator of cytokine (in particular IFN)-induced catabolism of tryptophan, and serum interleukin-8 (IL-8) before starting therapy and 2, 4, 16 and 24 weeks after immunotherapy with IFN alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323228.RAcZsLzNqt4HP_EJJvNPUqe9ucEXTTsJMY1CoT6pM8UOY130_provenance.
- NP323228.RAcZsLzNqt4HP_EJJvNPUqe9ucEXTTsJMY1CoT6pM8UOY130_assertion evidence source_evidence_literature NP323228.RAcZsLzNqt4HP_EJJvNPUqe9ucEXTTsJMY1CoT6pM8UOY130_provenance.
- NP323228.RAcZsLzNqt4HP_EJJvNPUqe9ucEXTTsJMY1CoT6pM8UOY130_assertion SIO_000772 11443537 NP323228.RAcZsLzNqt4HP_EJJvNPUqe9ucEXTTsJMY1CoT6pM8UOY130_provenance.
- NP323228.RAcZsLzNqt4HP_EJJvNPUqe9ucEXTTsJMY1CoT6pM8UOY130_assertion wasDerivedFrom befree-2016 NP323228.RAcZsLzNqt4HP_EJJvNPUqe9ucEXTTsJMY1CoT6pM8UOY130_provenance.
- NP323228.RAcZsLzNqt4HP_EJJvNPUqe9ucEXTTsJMY1CoT6pM8UOY130_assertion wasGeneratedBy ECO_0000203 NP323228.RAcZsLzNqt4HP_EJJvNPUqe9ucEXTTsJMY1CoT6pM8UOY130_provenance.